Amicus Therapeutics Stock Price on December 4, 2024
| FOLD Stock | USD 9.57 0.32 3.24% |
Below is the normalized historical share price chart for Amicus Therapeutics extending back to May 31, 2007. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Amicus Therapeutics stands at 9.57, as last reported on the 19th of December, with the highest price reaching 9.93 and the lowest price hitting 9.41 during the day.
If you're considering investing in Amicus Stock, it is important to understand the factors that can impact its price. Amicus Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0802, which signifies that the company had a -0.0802% return per unit of risk over the last 3 months. Amicus Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Amicus Therapeutics' Mean Deviation of 1.71, risk adjusted performance of (0.05), and Standard Deviation of 2.78 to double-check the risk estimate we provide.
At present, Amicus Therapeutics' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 3 B, whereas Capital Stock is forecasted to decline to about 2.9 M. . At present, Amicus Therapeutics' Price Earnings To Growth Ratio is projected to increase slightly based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 27.46, whereas Price Earnings Ratio is projected to grow to (26.25). Amicus Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 31st of May 2007 | 200 Day MA 10.6826 | 50 Day MA 10.5128 | Beta 0.673 |
Amicus |
Sharpe Ratio = -0.0802
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | FOLD |
Estimated Market Risk
| 2.8 actual daily | 24 76% of assets are more volatile |
Expected Return
| -0.22 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Amicus Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Amicus Therapeutics by adding Amicus Therapeutics to a well-diversified portfolio.
Price Book 16.5256 | Enterprise Value Ebitda (35.99) | Price Sales 5.7925 | Shares Float 241.1 M | Wall Street Target Price 17.3333 |
Related Headline
Argenx NV Headline on 4th of December 2024
Polymer Capital Management HK LTD Has 3.58 Million Stake in ... by thelincolnianonline.com
Polymer Capital Management HK LTD cut its stake in shares of argenx SE by 34.0 percent during the 3rd quarter, Holdings Channel reports. The institutional investor owned 6,600 shares of the companys stock after selling 3,400 shares during the quarter. Polymer Capital Management HK LTDs holdings in argenx were worth 3,578,000 at
Amicus Therapeutics Valuation on December 4, 2024
It is possible to determine the worth of Amicus Therapeutics on a given historical date. On December 4, 2024 Amicus was worth 9.8 at the beginning of the trading date compared to the closed value of 9.86. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Amicus Therapeutics stock. Still, in general, we apply an absolute valuation method to find Amicus Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Amicus Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Amicus Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 9.90 | 9.99 | 9.72 | 9.79 | 2,068,442 | |
12/04/2024 | 9.80 | 9.99 | 9.75 | 9.86 | 1,685,165 |
| 9.80 | 9.89 | 9.72 | 9.76 | 1,730,897 |
| Backtest Amicus Therapeutics | | | Amicus Therapeutics History | | | Amicus Therapeutics Valuation | Previous | Next |
Amicus Therapeutics Trading Date Momentum on December 4, 2024
| On December 05 2024 Amicus Therapeutics was traded for 9.76 at the closing time. The top price for the day was 9.89 and the lowest listed price was 9.72 . The trading volume for the day was 1.7 M. The trading history from December 5, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 1.01% . The overall trading delta against the current closing price is 4.97% . |
Amicus Therapeutics Fundamentals Correlations and Trends
By evaluating Amicus Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Amicus Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Amicus financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Amicus Therapeutics Stock history
Amicus Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Amicus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Amicus Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Amicus Therapeutics stock prices may prove useful in developing a viable investing in Amicus Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 295.2 M | 309.9 M | |
| Net Loss | -212.9 M | -223.6 M |
Amicus Therapeutics Quarterly Net Working Capital |
|
Amicus Therapeutics Stock Technical Analysis
Amicus Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Amicus Therapeutics Period Price Range
Low | December 19, 2024
| High |
0.00 | 0.00 |
Amicus Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Amicus Therapeutics December 19, 2024 Market Strength
Market strength indicators help investors to evaluate how Amicus Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Amicus Therapeutics shares will generate the highest return on investment. By undertsting and applying Amicus Therapeutics stock market strength indicators, traders can identify Amicus Therapeutics entry and exit signals to maximize returns
Amicus Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Amicus Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Amicus Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Amicus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.22) | |||
| Total Risk Alpha | (0.28) | |||
| Treynor Ratio | (0.34) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Amicus Stock analysis
When running Amicus Therapeutics' price analysis, check to measure Amicus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amicus Therapeutics is operating at the current time. Most of Amicus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Amicus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amicus Therapeutics' price. Additionally, you may evaluate how the addition of Amicus Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |